What governments, regulators and agencies decide, and what it changes.
Chancellor John Healey's Budget adds £190 million for the NHS in England this winter, £100 million to expand robot-assisted surgery to 500,000 operations a year by 2035, and a review of NHS productivity and AI.
A proposed CMS rule would require exchanges to verify income, citizenship, residence and other coverage before paying premium tax credits, starting with 2028 plans. CMS projects 332,500 fewer enrollees a year.
Medicare's telehealth flexibilities run through December 31, 2027 under the 2026 appropriations law, but clinics face a new billing rule now and the DEA's prescribing waiver ends December 31, 2026.
The FDA issued final guidance on software that drugmakers distribute with prescription medicines, setting out when app content counts as labeling, when it belongs in prescribing information and what must be submitted.
The 2026 update to the National Plan to Address Alzheimer's Disease replaces six goals with four, leads with dementia risk reduction, and comes with a new FDA accelerator and up to $48.8 million from ARPA-H.
HHS released a Kidney Care National Plan built on three priorities: preventing kidney failure, restoring competition in dialysis and reforming transplants. It sets direction but no targets or funding.
The World Health Organization and INTERPOL signed a cooperation agreement covering chemical and biological incidents, mass gatherings, organ trafficking, falsified medical products and tobacco control.
The EMA's human medicines committee recommended EU approval of Rasonque (daraxonrasib) for previously treated metastatic pancreatic cancer, citing median survival of 12.4 months versus 6.7 on chemotherapy.
The FDA announced a Rare Disease Framework Initiative and a white paper setting out six commitments to make reviews of rare disease drugs more consistent, with a public meeting set for October 28.
The FDA approved a surgical pulmonary valve for children that is implanted at about 13 mm and can later be widened by balloon catheter to 22 mm, which the agency says may reduce repeat open-heart surgery.
